1
|
Zhou Y, You MJ, Young KH, Lin P, Lu G,
Medeiros LJ and Bueso-Ramos CE: Advances in the molecular
pathobiology of B-lymphoblastic leukemia. Hum Pathol. 43:1347–1362.
2012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Zuckerman T and Rowe JM: Pathogenesis and
prognostication in acute lymphoblastic leukemia. F1000Prime Rep.
6:592014. View
Article : Google Scholar : PubMed/NCBI
|
3
|
Woo JS, Alberti MO and Tirado CA:
Childhood B-acute lymphoblastic leukemia: A genetic update. Exp
Hematol Oncol. 3:162014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Chapiro E, Russell LJ, Struski S, Cavé H,
Radford-Weiss I, Valle VD, Lachenaud J, Brousset P, Bernard OA,
Harrison CJ and Nguyen-Khac F: A new recurrent translocation
t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell
progenitor acute lymphoblastic leukemia. Leukemia. 24:1362–1364.
2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Russell LJ, Enshaei A, Jones L, Erhorn A,
Masic D, Bentley H, Laczko KS, Fielding AK, Goldstone AH, Goulden
N, et al: IGH@ translocations are prevalent in teenagers and young
adults with acute lymphoblastic leukemia and are associated with a
poor outcome. J Clin Oncol. 32:1453–1462. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Chapiro E, Russell L, Radford-Weiss I,
Bastard C, Lessard M, Struski S, Cave H, Fert-Ferrer S, Barin C,
Maarek O, et al: Overexpression of CEBPA resulting from the
translocation t(14;19)(q32;q13) of human precursor B acute
lymphoblastic leukemia. Blood. 108:3560–3563. 2006. View Article : Google Scholar : PubMed/NCBI
|
7
|
Gallego M, Coccé M, Felice M, Rossi J,
Eandi S, Sciuccati G and Alonso C: A new case of t(5;14)(q31;q32)
in a pediatric acute lymphoblastic leukemia presenting with
hypereosinophilia. Atlas Genet Cytogenet Oncol Haematol.
16:183–184. 2012.
|
8
|
Russell LJ, De Castro DG, Griffiths M,
Telford N, Bernard O, Panzer-Grümayer R, Heidenreich O, Moorman AV
and Harrison CJ: A novel translocation, t(14;19)(q32;p13),
involving IGH@ and the cytokine receptor for erythropoietin.
Leukemia. 23:614–617. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Moorman AV, Schwab C, Ensor HM, Russell
LJ, Morrison H, Jones L, Masic D, Patel B, Rowe JM, Tallman M, et
al: IGH@ translocations, CRLF2 deregulation and microdeletions in
adolescents and adults with acute lymphoblastic leukemia. J Clin
Oncol. 30:3100–3108. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Dyer MJ, Akasaka T, Capasso M, Dusanjh P,
Lee YF, Karran EL, Nagel I, Vater I, Cario G and Siebert R:
Immunoglobulin heavy chain locus chromosomal translocations in
B-cell precursor acute lymphoblastic leukemia: Rare clinical curios
or potent genetic drivers? Blood. 115:1490–1499. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Russell LJ, Akasaka T, Majid A, Sugimoto
KJ, Karran Loraine E, Nagel I, Harder L, Claviez A, Gesk S, Moorman
AV, et al: t(6;14)(p22;q32): A new recurrent IGH@ translocation
involving ID4 in B-cell precursor acute lymphoblastic leukemia
(BCP-ALL). Blood. 111:387–391. 2008. View Article : Google Scholar : PubMed/NCBI
|
12
|
Kim M, Yim SH, Cho NS, Kang SH, Ko DH, Oh
B, Kim TY, Min HJ, She CJ, Kang HJ, et al: Homozygous deletion of
CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic
factor in adult but not in childhood B-lineage acute lymphoblastic
leukemia: A comparative deletion and hypermethylation study. Cancer
Genet Cytogenet. 195:59–65. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Mullighan CG: The molecular genetic makeup
of acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ
Program. 2012:389–396. 2012.PubMed/NCBI
|
14
|
Usvasalo A, Savola S, Räty R, Vettenranta
K, Harila-Saari A, Koistinen P, Savolainen ER, Elonen E,
Saarinen-Pihkala UM and Knuutila S: CDKN2A deletions in acute
lymphoblastic leukemia of adolescents and young adults: An array
CGH study. Leuk Res. 32:1228–1235. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Robak T, Szmigielska-Kapłon A,
Wrzesień-Kuś A, Wierzbowska A, Skotnicki AB, Piatkowska-Jakubas B,
Kuliczkowski K, Mazur G, Zduńczyk A, Stella-Hołowiecka B, et al:
Acute lymphoblastic leukemia in elderly: The Polish Adult Leukemia
Group (PALG) experience. Ann Hematol. 83:225–231. 2004. View Article : Google Scholar : PubMed/NCBI
|
16
|
Claussen U, Michel S, Mühlig P, Westermann
M, Grummt UW, Kromeyer-Hauschild K and Liehr T: Demystifying
chromosome preparation and the implications for the concept of
chromosome condensation during mitosis. Cytogenet Genome Res.
98:136–146. 2002. View Article : Google Scholar : PubMed/NCBI
|
17
|
Shaffer LG, McGowan-Jordan J and Schmid M:
An International System for Human Cytogenetic Nomenclature (2013)
(1st). Basel: Karger Publishers. 2013.
|
18
|
Liehr T: Fluorescence In Situ
Hybridization (FISH) - Application Guide (1st). Berlin: Springer
Verlag Berlin Heidelberg. 2009. View Article : Google Scholar
|
19
|
Liehr T, Heller A, Starke H, Rubtsov N,
Trifonov V, Mrasek K, Weise A, Kuechler A and Claussen U:
Microdissection based high resolution multicolor banding for all 24
human chromosomes. Int J Mol Med. 9:335–339. 2002.PubMed/NCBI
|
20
|
Weise A, Heller A, Starke H, Mrasek K,
Kuechler A, Pool-Zobel BL, Claussen U and Liehr T: Multitude
multicolor chromosome banding (mMCB) - a comprehensive one-step
multicolor FISH banding method. Cytogenet Genome Res. 103:34–39.
2003. View Article : Google Scholar : PubMed/NCBI
|
21
|
Weise A, Mrasek K, Fickelscher I, Claussen
U, Cheung SW, Cai WW, Liehr T and Kosyakova N: Molecular definition
of high-resolution multicolor banding probes: First within the
human DNA sequence anchored FISH banding probe set. J Histochem
Cytochem. 56:487–493. 2008. View Article : Google Scholar : PubMed/NCBI
|
22
|
Othman MA, Melo JB, Carreira IM, Rincic M,
Alhourani E, Wilhelm K, Gruhn B, Glaser A and Liehr T: MLLT10 and
IL3 rearrangement together with a complex four-way translocation
and trisomy 4 in a patient with early T-cell precursor acute
lymphoblastic leukemia: A case report. Oncol Rep. 33:625–630.
2015.PubMed/NCBI
|
23
|
Han Y, Xue Y, Zhang J, Wu Y, Pan J, Wang
Y, Shen J, Dai H and Bai S: Translocation (14;14)(q11;q32) with
simultaneous involvement of the IGH and CEBPE genes in B-lineage
acute lymphoblastic leukemia. Cancer Genet Cytogenet. 187:125–129.
2008. View Article : Google Scholar : PubMed/NCBI
|
24
|
Mitelman F, Johansson B and Mertens F:
Mitelman Database of Chromosome Aberrations and Gene Fusions in
Cancer (2014). http://cgap.nci.nih.gov/Chromosomes/MitelmanAccessed.
December. 2014
|
25
|
Sheth F, Ewers E, Kosyakova N, Weise A,
Sheth J, Patil S, Ziegler M and Liehr T: A neocentric isochromosome
Yp present as additional small supernumerary marker chromosome -
evidence against U-type exchange mechanism? Cytogenet Genome Res.
125:115–116. 2009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Braggio E, McPhail ER, Macon W, Lopes MB,
Schiff D, Law M, Fink S, Sprau D, Giannini C, Dogan A, et al:
Primary central nervous system lymphomas: A validation study of
array-based comparative genomic hybridization in formalin-fixed
paraffin-embedded tumor specimens. Clin Cancer Res. 17:4245–4253.
2011. View Article : Google Scholar : PubMed/NCBI
|
27
|
Parker H, An Q, Barber K, Case M, Davies
T, Konn Z, Stewart A, Wright S, Griffiths M, Ross FM, et al: The
complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic
leukemia highlights a recurrent deletion of TBL1XR1. Genes
Chromosomes Cancer. 47:1118–1125. 2008. View Article : Google Scholar : PubMed/NCBI
|
28
|
Chan TH, Lin CH, Qi L, Fei J, Li Y, Yong
KJ, Liu M, Song Y, Chow RK, Ng VH, et al: A disrupted RNA editing
balance mediated by ADARs (Adenosine DeAminases that act on RNA) in
human hepatocellular carcinoma. Gut. 63:832–843. 2014. View Article : Google Scholar : PubMed/NCBI
|
29
|
Paz N, Levanon EY, Amariglio N, Heimberger
AB, Ram Z, Constantini S, Barbash ZS, Adamsky K, Safran M,
Hirschberg A, et al: Altered adenosine-to-inosine RNA editing in
human cancer. Genome Res. 17:1586–1595. 2007. View Article : Google Scholar : PubMed/NCBI
|
30
|
Clappier E, Auclerc MF, Rapion J, Bakkus
M, Caye A, Khemiri A, Giroux C, Hernandez L, Kabongo E, Savola S,
et al: An intragenic ERG deletion is a marker of an oncogenic
subtype of B-cell precursor acute lymphoblastic leukemia with a
favorable outcome despite frequent IKZF1 deletions. Leukemia.
28:70–77. 2014. View Article : Google Scholar : PubMed/NCBI
|
31
|
Marcucci G, Baldus CD, Ruppert AS,
Radmacher MD, Mrózek K, Whitman SP, Kolitz JE, Edwards CG, Vardiman
JW, Powell BL, et al: Overexpression of the ETS-related gene, ERG,
predicts a worse outcome in acute myeloid leukemia with normal
karyotype: A Cancer and Leukemia Group B study. J Clin Oncol.
23:9234–9242. 2005. View Article : Google Scholar : PubMed/NCBI
|
32
|
Davidson AE, Schwarz N, Zelinger L,
Stern-Schneider G, Shoemark A, Spitzbarth B, Gross M, Laxer U,
Sosna J, Sergouniotis PI, et al: Mutations in ARL2BP, encoding
ADP-ribosylation-factor-like 2 binding protein, cause
autosomal-recessive retinitis pigmentosa. Am J Hum Genet.
93:321–329. 2013. View Article : Google Scholar : PubMed/NCBI
|
33
|
Pass HI, Liu Z, Wali A, Bueno R, Land S,
Lott D, Siddiq F, Lonardo F, Carbone M and Draghici S: Gene
expression profiles predict survival and progression of pleural
mesothelioma. Clin Cancer Res. 10:849–859. 2004. View Article : Google Scholar : PubMed/NCBI
|
34
|
Shoichet SA, Hoffmann K, Menzel C,
Trautmann U, Moser B, Hoeltzenbein M, Echenne B, Partington M, Van
Bokhoven H, Moraine C, et al: Mutations in the ZNF41 gene are
associated with cognitive deficits: Identification of a new
candidate for X-linked mental retardation. Am J Hum Genet.
73:1341–1354. 2003. View
Article : Google Scholar : PubMed/NCBI
|